NCT07442461 is a NA clinical trial of VIS4ION Platform in Visual Impairment, sponsored by NYU Langone Health.

Who is sponsoring NCT07442461?

NCT07442461 is sponsored by NYU Langone Health.

What drugs are being tested in NCT07442461?

Interventions in NCT07442461: VIS4ION Platform.

What condition does NCT07442461 study?

NCT07442461 studies Visual Impairment.

Is NCT07442461 still recruiting?

NCT07442461 is currently not yet recruiting. Last updated 2 March 2026.

Last reviewed 2026-03-02 · How we verify

NCT07442461

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Virtual Assistance for Daily Living: Neurophysiological and Functional Effects in Low Vision

Not yet recruiting NA Last updated 2 March 2026

What this trial tests

NA trial testing VIS4ION Platform in Visual Impairment in 150 participants. Not yet recruiting.

Timeline

1 March 2026

Primary endpoint
30 December 2028

30 December 2028

Quick facts

Lead sponsor	NYU Langone Health
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	150
Start date	1 March 2026
Primary completion	30 December 2028
Estimated completion	30 December 2028
Sites	1 location across United States

Drugs / interventions tested

VIS4ION Platform

Conditions studied

Visual Impairment — all drugs for Visual Impairment →

Sponsor

NYU Langone Health — full company profile →

Who can join

Adults 18 to 80, any sex, with Visual Impairment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate how visual impairment affects neurophysiological and biomechanical responses during real-world navigation and daily activities, with a focus on the rehabilitative feasibility and impact of assistive technologies. These technologies include applications and wearable devices designed to support various aspects of daily living for individuals with visual impairment. The VIS4ION platform (Visually Impaired Smart Service System for Spatial Intelligence \& On-board Navigation), a wearable system providing tactile and auditory feedback, is one component of this broader study. VIS4ION is designed to enhance environmental awareness and reduce cognitive load during mobility tasks for the visually impaired.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Visual Impairment

Currently open trials in the same condition.

NCT06984822 — Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant · NA · recruiting
NCT07055646 — Influence of Low Vision Assistive Technology on Mobility Among Visually Impaired Individuals · active not recruiting
NCT06877988 — Artificial Intelligence (AI) - Assisted Visual Impairment Screening Model: Community-based Implementation and Evaluation · NA · active not recruiting
NCT06518148 — Causes of Visual Impairment Among Patients Applying for the Visually Disability Certification · active not recruiting
NCT06075147 — The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impair · active not recruiting

Other NYU Langone Health trials

Trials by the same sponsor.

NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study · NA · not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease · NA · not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors · NA · not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health · not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest · Phase 1 · suspended

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07442461 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 2 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07442461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing